Theraly Fibrosis
Germantown, US · Founded 2015 · Delaware corporation
Founders & leadership
VR
Viktor RoschkeNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$5.6M disclosed across 2 rounds · 2018
▶$4.9MraisedJun 2018 · 4 investors · PharmaceuticalsRule 506(b)
▶$4.9MraisedJun 2018 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Viktor RoschkeExecutive Officer, Director
- Keele ParkDirector
- Seulki LeeDirector
- Junghee LimDirector
- Offering amount
- $5M
- Amount sold
- $4.9M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$700KraisedMar 2018 · 3 investors · PharmaceuticalsRule 506(b)
▶$700KraisedMar 2018 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Viktor RoschkeExecutive Officer
- Offering amount
- $1M
- Amount sold
- $700K
- Minimum investment
- $200K
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Theraly Fibrosis raised?
- Theraly Fibrosis has disclosed $5.6M raised across 2 rounds.
- Where is Theraly Fibrosis headquartered?
- Theraly Fibrosis is headquartered in Germantown, US.